For 8.7 million Americans, today is a good day. That is precisely how many people take Lipitor, a cholesterol reducing drug. Today the profitable drugs patent expires, allowing it to be marketed as a generic for the first time ever. Last year alone, Lipitor earned its maker Pfizer over $5 billion dollars.
For users, a generic version will cost up to half as much as the brand name version. Considering its popularity amongst elderly users who are more likely to be on fixed incomes, this is welcome news.
To find out more, visit http://abcnews.go.com/Health/lipitor-generic-consumers-expect/story?id=15051397